Finally, the higher degree of cytoxicity against hypoxic cells compared to normoxic cells provides further evidence that complex 1 targets HIF-1α, and also raises the possibility that the compound could be developed into a possible anticancer lead, due to hypoxic environment that normally develops around tumor tissues. The gene discussed is HIF1A; the disease is neoplasm.